Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 104370

In scope icon M 6 E
QID 104370 (Type "104370" in App Search)
A 43-year-old male with a history of thyroid cancer status post total thyroidectomy presents to his primary care physician after repeated bouts of headaches. His headaches are preceded by periods of anxiety, palpitations, and sweating. The patient says he is unable to pinpoint any precipitating factors and instead says the events occur without warning. Of note, the patient's father and uncle also have a history of thyroid cancer. On exam his vitals are: T 36.8 HR 87, BP 135/93, RR 14, and O2 Sat 100% on room air. The patient's TSH is within normal limits, and he reports taking his levothyroxine as prescribed. What is the next best step in diagnosing this patient's chief complaint?

Abdominal CT scan with and without IV contrast

23%

5/22

24-hour urine free cortisol

0%

0/22

High dose dexamethasone suppression test

0%

0/22

Plasma fractionated metanephrines

64%

14/22

Plasma aldosterone/renin ratio

5%

1/22

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient with a familial and personal history of thyroid cancer, is now presenting with periods of diaphoresis, anxiety, palpitations, concerning for elevated catecholamines secondary to a pheochromocytoma in the setting of Multiple Endocrine Neoplasia Type II (MEN II). The first line test for diagnosing a pheochromocytoma is elevated plasma fractionated metanephrines.

MEN IIa is caused by an autosomal dominant inherited germline RET mutation and is characterized by endocrine tumors. Patients are specifically at an elevated risk for developing medullary thyroid cancer, pheochromocytomas, and primary parathyroid hyperplasia. Medullary thyroid cancer is often the first presenting tumor, with peak incidence in the third decade of life. Pheochromocytomas are rarely the first tumor, but can be screened for if there is known familial inheritance. Treatment for pheochromocytomas is surgical excision.

Brandi et. al. discuss the MEN syndromes in depth, and comment that most deaths from MEN II occur as a result of medullary thyroid cancer progression, not from pheochromocytomas. Early thyroidectomy in childhood, is thus recommended in suspected individuals with a familial history once a germline mutation is confirmed.

Pappachan et. al. discuss the diagnosis and management of pheochromocytomas. They comment that the majority (85%) of pheochromocytomas occur in the adrenal medulla. Additionally, preoperative management with alpha blockade is critical for improved surgical outcomes.

Incorrect Answers:
Answer 1: Abdominal CT scan is important for surgical planning prior to resection of pheochromocytomas, in particular to assess for bilateral and extra adrenal disease. This is not the first line test for diagnosis, however.
Answer 2: 24-hour free cortisol is a proper diagnostic test for patients suspected of Cushing's syndrome, not of pheochromocytomas.
Answer 3: High dose dexamethasone suppression test in used to determine whether elevated ACTH is being produced centrally or peripherally in the setting of Cushing's syndrome.
Answer 5: Plasma aldosterone/renin is the test of choice for the diagnosis of aldosterone secreting tumors.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

4.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(4)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options